![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
PharmiWeb.com: The Heart of Life Sciences on the Web
PharmiWeb.com - Global pharma news from the pharmaceutical industry, biotech, clinical research, life science & healthcare. Pharma Events Listings, Pharma Company Directory & pharma jobs.
2025 Clinical Trials Outlook: Six industry trends to expect
Dec 20, 2024 · Rising costs, shifting regulations, and the surge of artificial intelligence (AI) have been hot topics in the industry this year and are trends that will continue into 2025. At Velocity, we’re bracing for a year defined by technology-driven efficiencies, an …
ICR welcomes NICE recommendation of olaparib for advanced …
Jan 9, 2025 · The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer.
ACG Expands Global Footprint with New Capsule Manufacturing …
Dec 19, 2024 · ACG, a leading global supplier of integrated manufacturing solutions for the pharmaceutical and nutraceutical industries, has announced the commencement of operations at its state-of-the-art capsule manufacturing facility in Rayong, Thailand. The new facility, the largest of its kind in Thailand, is dedicated to ...
2024 ABPI Code of Practice launched, with a new constitution and ...
Sep 23, 2024 · The Association of the British Pharmaceutical Industry (ABPI) and the Prescription Medicines Code of Practice Authority (PMCPA) have published an updated Code of Practice for the pharmaceutical industry. The ABPI Code of Practice is the research-based pharmaceutical industry’s commitment to operate in a professional, ethical, and transparent manner, for the benefit of patients and the public ...
Sanofi initiates phase 3 program for PCV21 and expands …
Jan 2, 2025 · Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop, license and commercialize next-generation PCVs for both pediatric and adult populations, reaffirming their commitment to fighting pneumococcal disease.
PLL Therapeutics appoints Dr. Souad Kechairi as chief medical officer
Oct 28, 2024 · Dr. Kechairi strengthens clinical team to advance PLL Therapeutics’ autoimmune and neurodegenerative diseases pipeline and enter phase 1 clinical trials with lead candidate for Amyotrophic Lateral Sclerosis (ALS)Villenave-d’Ornon (near Bordeaux) France, October 28, 2024 – PLL Therapeutics, a biop...
Ovalbumin: The Multifaceted Protein from Egg White
Sep 25, 2024 · Ovalbumin, also known as albumin or OVA, is the most abundant protein found in egg white, accounting for approximately 54% of its total protein content. This versatile glycoprotein has captivated researchers and industry professionals alike due to its unique properties and wide-ranging applications. In this article, we'll explore the structure, functions, and diverse uses of ovalbumin in ...
Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated ...
Paris, October 25, 2024 Q3 sales growth of 15.7% at CER and business EPS(1) of €2.86 Dupixent sales up 23.8% to €3,476 million; full-year 2024 target of ~€13 billion confirmed Pharma launches up 67.1% to €727 million, led by ALTUVIIIO, Nexviazyme and Rezurock Vaccines sales up 25.5%, boosted by phasing of flu sales, and by Beyfortus due to approved extra capacity Opella up 7.9%, driven ...
REMORY: A Sea Squirt-Derived Plasmalogen Supplement Expands …
Nov 7, 2024 · REMORY: Elevate Cognitive Health with Unique Sea Squirt-Derived Plasmalogens. Now in the U.S., this Japanese-Innovated Supplement Combines EPA, DHA, and Omega-3s for Enhanced Memory and Brain Function in Aging Adults. Recognized by Japan as a 'Food with Functional Claims,' REMORY is FDA-Notified, Setting a New Standard in Natural Cognitive Support. LOS ANGELES, CA / ACCESSWIRE / November 7 ...